BVF I GP LLC

See Explanation of Responses at CTI BIOPHARMA CORP · on record since Jun 28, 2023
10% owner at PALVELLA THERAPEUTICS, INC. · on record since May 22, 2023
Director at Olema Pharmaceuticals, Inc. · on record since Jun 21, 2023
See explanation of responses at Structure Therapeutics Inc. · on record since Feb 13, 2023
See Explanation of Responses at enGene Therapeutics Inc. · on record since Nov 13, 2023
See Explanation of Responses at POINT Biopharma Global Inc. · on record since Nov 6, 2023
Director at Rain Oncology Inc. · on record since Jan 29, 2024
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Apr 27, 2021
See Explanation of Responses at Allakos Inc. · on record since Jan 26, 2024
See Explanation of Responses at PALVELLA THERAPEUTICS, INC. · on record since Dec 17, 2024
Director at IMMUNIC, INC. · on record since Feb 27, 2026
See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
Director at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at XOMA Royalty Corp · on record since May 18, 2026
10% owner at CTI BIOPHARMA CORP · on record since Mar 4, 2020
See Explanation of Responses at IDEAYA Biosciences, Inc. · on record since Jun 22, 2020
10% owner at FIVE PRIME THERAPEUTICS, INC. · on record since May 18, 2020
See Explanation of Responses at · on record since Jun 10, 2020
See Explanation of Responses at · on record since Aug 20, 2020
10% owner at · on record since Sep 17, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 20, 2020
10% owner at · on record since Nov 19, 2020
See Explanation of Responses at · on record since Nov 13, 2020
10% owner at · on record since Nov 6, 2020
See Explanation of Responses at · on record since Nov 3, 2020
See Explanation of Responses at · on record since Jan 26, 2021
See Explanation of Responses at · on record since Nov 8, 2021
See Explanation of Responses at · on record since Jan 10, 2022
See Explanation of Responses at · on record since Feb 7, 2022
See Explanation of Responses at · on record since Jun 27, 2022
Director at · on record since May 20, 2022
10% owner at · on record since Jun 15, 2022
10% owner at · on record since Jul 21, 2022
Director at · on record since Aug 11, 2022
See Explanation of Responses at · on record since Dec 22, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Aug 25, 2020
10% owner at · on record since Oct 5, 2026

Insider trading activity of BVF I GP LLC

Transactions on record: 49; since Jul 2, 2020

Open-market buys: 25; $7.8M

Open-market sells: 12; $176.6M

Companies traded: 8; last filing Dec 17, 2024

Figures computed from official regulatory filings — .

Companies where BVF I GP LLC has traded

3 tx · Dec 17, 2024
6 tx · Nov 13, 2024
3 tx · $100M · Oct 8, 2024
3 tx · $24.7M · Jan 9, 2024
13 tx · $2M · Sep 16, 2022
12 tx · $78.8M · Oct 8, 2021
6 tx · $3.5M · May 20, 2021
3 tx · $33.7K · Jul 2, 2020

Track record of BVF I GP LLC

Statistical track record

Free account

Open-market buys: 28

Last buy: Jan 5, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of BVF I GP LLC

Co-insiders of BVF I GP LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 17, 2024	Other	174,958	—	n/a (No price was disclosed in the filing)		SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 17, 2024	Other	234,323	—	n/a (No price was disclosed in the filing)		SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 17, 2024	Other	29,648	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	OtherD (derivative)	240,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	Other	-2,378,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	OtherD (derivative)	2,378,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	OtherD (derivative)	3,062,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	Other	-240,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	Other	-3,062,000	—	n/a (No price was disclosed in the filing)		SEC
MoonLake ImmunotherapeuticsListing on record	Oct 8, 2024	Sell	-836,862	50.00 USD	$41.8M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 8, 2024	Sell	-1,030,589	50.00 USD	$51.5M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 8, 2024	Sell	-132,549	50.00 USD	$6.6M		SEC
Kymera Therapeutics, Inc.Listing on record	Jan 9, 2024	BuyD (derivative)	52,733	25.25 USD	$1.3M	First in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jan 9, 2024	BuyD (derivative)	550,425	25.25 USD	$13.9M	Unusual sizeFirst in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jan 9, 2024	BuyD (derivative)	375,856	25.25 USD	$9.5M	Unusual sizeFirst in 12mo	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	5,575	17.96 USD	$100.1K	conv 10	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	10,897	17.89 USD	$194.9K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	13,396	17.89 USD	$239.7K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	26,441	17.25 USD	$456.1K	conv 26First in 12mo	SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-80,011	27.79 USD	$2.2M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-530,999	27.53 USD	$14.6M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-384,914	27.53 USD	$10.6M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-58,327	27.79 USD	$1.6M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-69,534	27.53 USD	$1.9M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-8,929	27.79 USD	$248.1K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 17, 2024	Other	174,958	—	n/a (No price was disclosed in the filing)		SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 17, 2024	Other	234,323	—	n/a (No price was disclosed in the filing)		SEC
PALVELLA THERAPEUTICS, INC.Listing unverified	Dec 17, 2024	Other	29,648	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	OtherD (derivative)	240,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	Other	-2,378,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	OtherD (derivative)	2,378,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	OtherD (derivative)	3,062,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	Other	-240,000	—	n/a (No price was disclosed in the filing)		SEC
4D Molecular Therapeutics, Inc.Listing on record	Nov 13, 2024	Other	-3,062,000	—	n/a (No price was disclosed in the filing)		SEC
MoonLake ImmunotherapeuticsListing on record	Oct 8, 2024	Sell	-836,862	50.00 USD	$41.8M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 8, 2024	Sell	-1,030,589	50.00 USD	$51.5M	Unusual size	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 8, 2024	Sell	-132,549	50.00 USD	$6.6M		SEC
Kymera Therapeutics, Inc.Listing on record	Jan 9, 2024	BuyD (derivative)	52,733	25.25 USD	$1.3M	First in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jan 9, 2024	BuyD (derivative)	550,425	25.25 USD	$13.9M	Unusual sizeFirst in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jan 9, 2024	BuyD (derivative)	375,856	25.25 USD	$9.5M	Unusual sizeFirst in 12mo	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	5,575	17.96 USD	$100.1K	conv 10	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	10,897	17.89 USD	$194.9K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	13,396	17.89 USD	$239.7K	conv 21	SEC
XOMA Royalty CorpSecurity delisted	Sep 16, 2022	Buy	26,441	17.25 USD	$456.1K	conv 26First in 12mo	SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-80,011	27.79 USD	$2.2M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-530,999	27.53 USD	$14.6M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-384,914	27.53 USD	$10.6M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-58,327	27.79 USD	$1.6M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-69,534	27.53 USD	$1.9M		SEC
Merus N.V.Listing unverified	Oct 8, 2021	Sell	-8,929	27.79 USD	$248.1K		SEC